Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726036 · ClinicalTrials.gov registry record · NA
Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial
A NA study of Circumcision, Male, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 274
- Enrollment target
- 1
- Study location
NCT01726036: Completed NA study of Circumcision, Male, sponsored by TriHealth.
NCT01726036 is a NA study of Circumcision, Male that has completed, run by TriHealth. The registered enrollment target is 274 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01726036, a NA study of Circumcision, Male, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two commonly used circumcision clamps (Gomco and Mogen) to see which results in less neonatal pain.
Primary Outcome
Neonatal pain will be assessed by change in salivary cortisol, measured in mcg/dL., level pre and post procedure
Conditions Studied
Interventions
- DEVICE Gomco Circumcision Clamp
- DEVICE Mogen Circumcision Clamp
Study Locations (1)
Ohio
- TriHealth Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01726036 record still lists
NCT01726036 is an interventional study that assigns participants to a tested intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Circumcision, Male appearing as the primary indexed condition, and to 2 interventions - of which Gomco Circumcision Clamp is the first listed.
NCT01726036 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01726036 about?
NCT01726036 is a clinical study titled "Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial". The purpose of this study is to compare two commonly used circumcision clamps (Gomco and Mogen) to see which results in less neonatal pain.
What is the current status of trial NCT01726036?
This trial is currently completed. It is a NA study. The enrollment target is 274 participants. The study started on 2012-10. Estimated completion is 2014-09.
What conditions does trial NCT01726036 study?
This clinical trial studies the following conditions: Circumcision, Male.
What interventions are being tested in trial NCT01726036?
The interventions under investigation include: Gomco Circumcision Clamp (DEVICE), Mogen Circumcision Clamp (DEVICE).
Who is sponsoring clinical trial NCT01726036?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01726036 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01726036's enrollment target sits among peer trials
274 385th of 2000 higher than 1,615 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia